Secukinumab-induced Raynaud's phenomenon: first report in the literature

被引：6
|
作者：
Kobak, Senol [1 ]
机构：
[1] Istinye Univ, Fac Med, LIV Hosp, Dept Rheumatol, Canan Sokak 5, TR-34340 Ulus Istanbul, Turkey
来源：
THERAPEUTIC ADVANCES IN DRUG SAFETY | 2020年 / 11卷
关键词：
ankylosing spondylitis; Raynaud's phenomenon; secukinumab; DISEASE; DRUGS;
D O I：
10.1177/2042098620905976
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Secukinumab is an IL-17A antagonist that has proven efficacy in the treatment of patients with ankylosing spondylitis (AS) and psoriatic arthritis. Side effects of the drug include infections, skin rashes, and allergic reactions. Raynaud's phenomenon (RP), a vasospastic syndrome and an important feature of different connective tissue diseases, is not an expected finding in AS patients. This article reports the development of secukinumab-related RP in a 35-year-old female patient with AS. Treatment with secukinumab was continued and RP was treated with low-dose aspirin and a calcium-channel blocker.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Pharmacology of Raynaud's Phenomenon
    Roustit, Matthieu
    Khouri, Charles
    Blaise, Sophie
    Villier, Celine
    Carpentier, Patrick
    Cracowski, Jean-Luc
    THERAPIE, 2014, 69 (02): : 115 - 128
  • [42] Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
    Li, Ronghui
    Lei, Haibo
    Wang, Chunjiang
    Liu, Xiang
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2025, 30 (01) : 37
  • [43] The aetiology of Raynaud's phenomenon
    Turton, EPL
    Kent, PJ
    Kester, RC
    CARDIOVASCULAR SURGERY, 1998, 6 (05): : 431 - 440
  • [44] Use of nitroglycerin ointment to treat primary and secondary Raynaud's phenomenon: a systematic literature review
    Qiu, Olivia
    Chan, Theresa
    Luen, Matthew
    Cruz, Joseph E.
    Hermes-DeSantis, Evelyn R.
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (12) : 2209 - 2216
  • [45] Progressive Systemic Sclerosis With Negative Antinuclear Antibodies and Absence of Raynaud?s Phenomenon: A Case Report and Literature Review
    Falls, Anna C.
    Wrigley, Catherine
    Khanna, Surabhi A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [46] Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
    Zhang, Chen
    Kang, Tianlun
    Qian, Tangliang
    Ma, Mingwei
    Hou, Xiujuan
    Li, Chen
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 2879 - 2883
  • [47] Literature-related discovery (LRD): Potential treatments for Raynaud's phenomenon
    Kostoff, Ronald N.
    Block, Joel A.
    Stump, Jesse A.
    Johnson, Dustin
    TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2008, 75 (02) : 203 - 214
  • [48] Behaviour change interventions for the management of Raynaud's phenomenon: a systematic literature review
    Daniels, Jo
    Pauling, John D.
    Eccleston, Christopher
    BMJ OPEN, 2018, 8 (12):
  • [49] Comparative evaluation of dermoscopy and capillaroscopy in Raynaud's phenomenon
    Moreau, J.
    Dupond, A. -S.
    Dan, N.
    Untereiner, T.
    Vidal, C.
    Aubin, F.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2017, 144 (05): : 333 - 340
  • [50] The patient experience of Raynaud's phenomenon in systemic sclerosis
    Pauling, John D.
    Saketkoo, Lesley Ann
    Matucci-Cerinic, Marco
    Ingegnoli, Francesca
    Khanna, Dinesh
    RHEUMATOLOGY, 2019, 58 (01) : 18 - 26
12345